Company Name: Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The company is focused on the development of T-cell therapies designed to treat cancer.
Ticker Symbol: ADAP (NASDAQ)
Company Website: www.adaptimmune.com
Social Media: Adaptimmune Therapeutics LinkedIn
Headquarters: Oxford, UK